Abstract

Mutations in the SLC26A4 gene are a common cause of human hereditary hearing impairment worldwide. Previous studies have demonstrated that different SLC26A4 mutations have different pathogenetic mechanisms. By using a genotype-driven approach, we established a knock-in mouse model (i.e., Slc26a4tm2Dontuh/tm2Dontuh mice) homozygous for the common p.H723R mutation in the East Asian population. To verify the pathogenicity of the p.H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4tm1Dontuh/tm2Dontuh) by intercrossing Slc26a4+/tm2Dontuh mice with Slc26a4tm1Dontuh/tm1Dontuh mice, which segregated the c.919-2A>G mutation with an abolished Slc26a4 function. Mice were then subjected to audiologic assessments, a battery of vestibular evaluations, inner ear morphological studies, and noise exposure experiments. The results were unexpected; both Slc26a4tm2Dontuh/tm2Dontuh and Slc26a4tm1Dontuh/tm2Dontuh mice showed normal audiovestibular phenotypes and inner ear morphology, and they did not show significantly higher shifts in hearing thresholds after noise exposure than the wild-type mice. The results indicated not only the p.H723R allele was non-pathogenic in mice, but also a single p.H723R allele was sufficient to maintain normal inner ear physiology in heterozygous compound mice. There might be discrepancies in the pathogenicity of specific SLC26A4 mutations in humans and mice; therefore, precautions should be taken when extrapolating the results of animal studies to humans.

Highlights

  • Mutations in the SLC26A4 (PDS, GeneID: 5172) gene are the second most frequent cause of human hereditary hearing impairment worldwide, next to mutations in the GJB2 (GeneID: 2706) gene [1]

  • Recessive SLC26A4 mutations contribute to both Pendred syndrome (PS; MIM #274600) [9] and nonsyndromic hearing loss (DFNB4; MIM #600791) [10], which share the phenotypes of sensorineural hearing impairment (SNHI) accompanied by an enlarged vestibular aqueduct (EVA; MIM 603545) and/or incomplete partition of the cochlea (i.e., Mondini dysplasia), the phenotype of PS includes goiter

  • Audiological and Vestibular Phenotypes Wild-type mice (i.e., Slc26a4+/+), heterozygous mice (i.e., Slc26a4+/tm2Dontuh), and homozygous mice (i.e., Slc26a4tm2Dontuh/ tm2Dontuh) (n = 10 each) were subjected to audiological evaluations at 1, 3, 6, and 9 months. Both Slc26a4+/tm2Dontuh and Slc26a4tm2Dontuh/ tm2Dontuh mice had normal hearing up to 9 months (Fig. 2), indicating that the p.H723R allele does not lead to deafness in mice

Read more

Summary

Introduction

Mutations in the SLC26A4 (PDS, GeneID: 5172) gene are the second most frequent cause of human hereditary hearing impairment worldwide, next to mutations in the GJB2 (GeneID: 2706) gene [1]. SLC26A4 mutations can be identified in approximately 13–14% of deaf patients [2]. Recessive SLC26A4 mutations contribute to both Pendred syndrome (PS; MIM #274600) [9] and nonsyndromic hearing loss (DFNB4; MIM #600791) [10], which share the phenotypes of sensorineural hearing impairment (SNHI) accompanied by an enlarged vestibular aqueduct (EVA; MIM 603545) and/or incomplete partition of the cochlea (i.e., Mondini dysplasia), the phenotype of PS includes goiter. More than 100 SLC26A4 mutations have been identified Many affected patients suffer from progressive or fluctuating hearing loss [13], implying that the natural course can be halted with preventive or therapeutic measures if the pathogenetic mechanisms of SLC26A4 mutations are better elucidated

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call